Investor Presentaiton
Opportunity in pharma and medical device to cater the demand
I. Why Invest in Indonesia Health Industry?
Rising middle-class population and the rise of middle-class household income
☐ Upcoming demographic bonus
☐ Rising middle class lifestyle with increasing lifestyle-related diseases
Rising health awareness in the general public
Universal Healthcare Coverage as Indonesia's national priority are now
supported with enhancement in multiple supporting system
☐ Indonesian government aim to achieve health system resilience, especially by
improving pharma and med-devices sector
☐ As part of system transformation, Indonesia's Citizen-Health apps, integrating all
patients-related records, was launched on August 2022
Current market structure offers solid growth with lucrative return which are
open for majority-stake foreign ownership (as a priority sector)
□ Wide market opportunity available to support the growth
Major players in Indonesia have reported EBITDA Margin up to 33% in the last 5 years
TRADE
38th
PO
Indonesia
Exhibition Seminar | Business Matching Trade Mission
ASEAN
INDONESIA
2023
II. Innovation projects partnering with prominent industry players/institutions
PHARMACEUTICAL
1. Papilloguard (HPV Vaccine) by Etana Biotechnologies
Indonesia
2. Kgbio: Upgrade and Expansion of Biologic Manufacturing
Facility by Kgbio (Kalbe Farma Group)
3. New TB vaccine by PT Bio Farma (SOE Pharma Holding Co).
4. Human Papillomavirus Vaccine (HPV) by PT Bio Farma
Measles Rubella (MR) Vaccine by PT Bio Farma
5.
6. Indonesia Propolis for Therapy of COVID-19 by
Universitas Indonesia
Disclaimer:
Please feel free to explore further details by reaching out to us
MEDICAL DEVICES
7. Dialyser Project by PT Forsta Kalmedic Global
8. ViuMe by PT PathGen Diagnostik Teknologi
9. ColoMelt-Dx and PulmoAmp-Dx by PT PathGen Diagnostik
Teknologi
10. HPV and EBV Cancer-associated infection molecular
Screening Test by PT PathGen Diagnostik Teknologi
11. Cancer Prediction Model for Clinical Decision Support by PT
PathGen Diagnostik Teknologi
12. CentriFlo High Flow Oxygen Therapy Device by Universitas
Indonesia
13. Ventilator for ICU by Universitas Indonesia
LPS/IDIC's role is to support the Bloomberg CEO Forum, a part of the G20 Summit Side Event. All information provided here should not be considered/interpreted/understood as a form of guarantee to
obtain an investment offer, commitment and/or agreement. Commitment/agreement regarding investment is entirely the will of the party offering the proposal and the investor/donor.
© Lembaga Penjamin Simpanan (LPS)/Indonesia Deposit Insurance Corporation (IDIC)
III. Production facilities in Batang Integrated Industrial Zone (KITB) - the
strategically located industrial zone
Cluster 2 800 Ha
Cluster 1 3100 Ha
District 6 - FnB Industry
Effective area: 800 Ha (8%)
District 7-Township
District 1- Electronic
Industry
Effective area: 263 Ha (16%)
Electronic Industry
Battery Industry
District 2 - Textile Industry
Effective area: 300 Ha (18%)
Apparel Park
300 ha
Gless Industry
District 3- Automotive Industry
Effective area: 665 Ha (40%)
3 domestic
medical device
companies will
set up their
plants
•
•
•
PT Tawada
Healthcare;
PT Jayamas
Medika
Industri
(Onemed); and
PT Mursmedic
Jaya Mandiri
District 8-Recreation
District 5-Township
District 4 - Chemical Industry
Effective area: 287 Ha (17%)
District 9 - Township
Cluster 1 400 Ha
500 1,000
2,000
4,000 meView entire presentation